DUSP19 regulates IL-1ß-induced apoptosis and MMPs expression in rat chondrocytes through JAK2/STAT3 signaling pathway.
Biomed Pharmacother
; 96: 1209-1215, 2017 Dec.
Article
de En
| MEDLINE
| ID: mdl-29174854
Osteoarthritis (OA) is a disease with degeneration of articular cartilage and its development and progression is characterized by chondrocyte apoptosis. To examine whether DUSP19 and inhibitor of the JAK2/STAT3 will influence the response of rat chondrocytes cultured with IL-1ß. Dose-response studies were conducted under IL-1ß conditions. In separate experiments, chondrocytes were treated with an appropriate concentration of IL-1ß with either DUSP19-expressing constructs or AG490, whereas chondrocytes were also treated with DUSP19-RNA interference constructs with or without AG490. The expression of DUSP19, apoptosis markers, JAK2/STAT3 and phosphorylation of JAK2/STAT3 was measured by Real-time PCR and/or western blot assay. CCK-8 assay and Annexin V/propidium iodide staining was used to detect chondrocyte viability and apoptosis, respectively. IL-1ß dose-dependently decreased the expression of DUSP19 and the viability of chondrocytes. Chondrocytes with DUSP19 up-regulation inhibited IL-1ß-induced increases in the ratio of p-JAK2/JAK2 and p-STAT3/STAT3 expression as well as cell apoptosis. However, DUSP19 down-regulation mimicked the effect of IL-1ß on JAK2/STAT3 activity and chondrocyte apoptosis. AG490 inhibited JAK2/STAT3 activation as well as apoptosis in chondrocytes induced by IL-1ß or DUSP19 down-regulation, evidenced by decreased expression of Bax, Caspase-3 and increased Bcl-2 expression as well as MMP-3, -9 and -13 expressions. Taken together, our results demonstrate that DUSP19 up-regulation inhibited IL-1ß-induced chondrocytes apoptosis and MMPs expression through inactivating JAK2/STAT3 pathway.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Transduction du signal
/
Apoptose
/
Matrix metalloproteinases
/
Facteur de transcription STAT-3
/
Kinase Janus-2
/
Interleukine-1 bêta
/
Dual-specificity phosphatases
Limites:
Animals
Langue:
En
Journal:
Biomed Pharmacother
Année:
2017
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
France